BioHarvest (BHST) Q1 2026 Earnings Transcript
Key takeaways
- Motley Fool Transcribing, The Motley Fool Mon, May 18, 2026 at 8:08 PM GMT+7 43 min read BHST Image source: The Motley Fool.
- Need a quote from a Motley Fool analyst?
- Zaki Rakib: Thank you, Dory, and thank you all for joining us this morning.
Motley Fool Transcribing, The Motley Fool Mon, May 18, 2026 at 8:08 PM GMT+7 43 min read BHST Image source: The Motley Fool.
Need a quote from a Motley Fool analyst? Email pr@fool.com
Zaki Rakib: Thank you, Dory, and thank you all for joining us this morning. Bio Harvest Sciences is an industrial plant cell culture biotech company and a leader in Botanical Synthesis, which is a patented non-GMO platform technology that industrializes what nature otherwise does slowly and produces high-value plant-derived compounds and botanical compositions without growing the plant itself. Using proprietary plant cell biology, elicitation technologies, AI-driven development and industrial scale bioreactors, BioHarvest creates highly consistent, bioavailable and patent-protected precision botanics or compounds possessing enhanced potency and purity compared to the original plant, along with the characteristics for commercial scalability.